U.S. pharma giant copyright scrapped two experimental weight loss drugs very last 12 months—a once-day-to-day pill, lotiglipron, due to elevated liver enzymes and also a two times-every day tablet, danuglipron, because of solid Unintended effects—but CEO Albert Bourla has explained the company is determined to “Engage in and earn” during th